Toyota Motor gains 1.03 percent regardless of modest market pull down

  few days ago at Macroaxis 
By Ellen Johnson
Today's write-up is for all investors who are seriously contemplating on taking a position in Toyota Motor. I will summarize the rationale of why Toyota Motor stakeholders were not insulted from the new market pull down. Toyota Motor chance of financial distress is under   39.00&n... [more]
 risk ideas   toyota motor consumer cyclical auto manufacturers
The company is active under Consumer Cyclical sector as part of Auto Manufacturers industry. This firm dividends can provide a clue to current valuation of the stock. Toyota Motor one year expected dividend income is about $2.05 per share. Lets now take a look at Toyota Motor Price to Earning. Based on latest financial disclosure the price to earning indicator of Toyota Motor Corporation is roughly 8.68 times. This is 65.14% lower than that of the Consumer Cyclical sector, and 11.97% lower than that of Auto Manufacturers industry, The Price to Earning for all stocks is 69.78% higher than the company.
  over a week ago at Macroaxis 
By Vlad Skutelnik
Today I will outline PICO Holdings. I will go over what exactly are PICO Holdings shareholders getting in December. The company Piotroski F Score is 6 - Healthy. Given the investment horizon of 30 days, PICO Holdings is expected to generate 0.94 times more return on investment than the market. However, the company is 1.06 times less risky than the market. It trades about 0.18 of its potential returns per unit of risk. The market is currently generating roughly 0.12 per unit of risk. PICO Holdings owns latest Real Value of $21.78 per share. The recent price of the company is $10.97. At this time the company appears to be undervalued. This module determines value of PICO Holdings from analyzing the company fundamentals such as Return On Asset of 0.014  and Operating Margin of 17.41  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support to invest in undervalued equities and to dispose of overvalued equities since in the future instruments prices and their ongoing real values will converge.
 PICO Holdings  risk ideas   pico holdings utilities utilities - regulated water real estate utilities?regulated water
  over a week ago at Macroaxis 
By Vlad Skutelnik
This post will digest BOK Financial. I will evaluate if BOK Financial shares are reasonably priced going into December. BOK Financial Piotroski F Score is 2 - Frail. Given the investment horizon of 30 days, BOK Financial is expected to generate 1.32 times less return on investment than the market. In addition to that, the company is 1.01 times more volatile than its market benchmark. It trades about 0.1 of its total potential returns per unit of risk. The market is currently generating roughly 0.14 per unit of volatility. We found thirty-three available fundamental indicators for BOK Financial Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all BOK Financial fundamentals including its Shares Owned by Insiders, Revenue, Total Debt, as well as the relationship between Price to Earning and Net Income . Given that BOK Financial has Number of Shares Shorted of 971.82 K, we suggest you validate BOK Financial Corporation prevailing market performance to make sure the company can sustain itself for few more years. Use BOK Financial to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of BOK Financial to be traded at $92.3 in 30 days.
 BOK Financial  risk ideas   bok financial financial services banks - regional banking banks?regional
  over a week ago at Macroaxis 
By Vlad Skutelnik
In this article I will break down Royal Bank. I will evaluate if Royal Bank shares are reasonably priced going into December. Royal Bank chance of financial distress is under   36.00  . Allowing for the 30-days total investment horizon, Royal Bank is expected to generate 0.47 times more return on investment than the market. However, the company is 2.12 times less risky than the market. It trades about 0.28 of its potential returns per unit of risk. The market is currently generating roughly 0.1 per unit of risk. We found thirty-one available financial ratios for Royal Bank which can be compared to its competitors. To make sure the equity is not overpriced, please check all Royal Bank fundamentals including its Short Ratio, Total Asset and the relationship between Debt to Equity and Number of Employees . Given that Royal Bank has Number of Shares Shorted of 4.31 M, we recommend you check out Royal Bank recent market performance to make sure the company can sustain itself down the road. Use Royal Bank to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Royal Bank to be traded at $86.31 in 30 days.
 Royal Bank  risk ideas   royal bank financial services banks?diversified
  over a week ago at Macroaxis 
By Ellen Johnson
In this review I will examine Merck. I will concentrate on why it could still be a good year for Merck traders. This firm Piotroski F Score is 5 - Healthy. Considering 30-days investment horizon, Merck is expected to generate 1233.0 times less return on investment than the market. But when comparing it to its historical volatility, the company is 1.01 times less risky than the market. It trades about 0.0 of its potential returns per unit of risk. The market is currently generating roughly 0.1 of returns per unit of risk over similar time horizon. What is Merck Target Price Odds to finish over Current Price? Coming from normal probability distribution, the odds of Merck to move above current price in 30 days from now is about 18.98%. The Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 30 days . Considering 30-days investment horizon, Merck has beta of 0.0949 indicating as returns on market go up, Merck average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Merck Company will be expected to be much smaller as well. Additionally, the company has a negative alpha implying that the risk taken by holding this equity is not justified. Merck is significantly underperforming Russell 2000 .
 Merck  risk ideas   merck healthcare drug manufacturers - general pharmaceutical products drug manufacturers?general
  over two weeks ago at Macroaxis 
By Achuva Shats
This piece will outline Zions Bancorporation. I will inspect the possibilities of making Zions Bancorporation into a steady grower in December. This firm Piotroski F Score is 4 - Ordinary. Given the investment horizon of 30 days, Zions Bancorporation is expected to generate 1.21 times more return on investment than the market. However, the company is 1.21 times more volatile than its market benchmark. It trades about 0.21 of its potential returns per unit of risk. The market is currently generating roughly 0.1 per unit of risk. Macroaxis considers Zions Bancorporation very steady given 1 month investment horizon. Zions Bancorporation shows Sharpe Ratio of 0.2143 which attests that the company had 0.2143% of return per unit of risk over the last 1 month. Our philosophy towards determining volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Zions Bancorporation which you can use to evaluate future volatility of the organization. Please utilize Zions Bancorporation Mean Deviation of 1.21, Downside Deviation of 1.53 and Market Risk Adjusted Performance of 0.3556 to validate if our risk estimates are consistent with your expectations.
 Zions Bancorporation  risk ideas   zions bancorporation services banking financial services banks?regional
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
This post will go over Columbia Banking. I will evaluate why recent Columbia Banking price moves suggest a bounce in December. The company Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, Columbia Banking is expected to generate 0.98 times more return on investment than the market. However, the company is 1.02 times less risky than the market. It trades about 0.19 of its potential returns per unit of risk. The market is currently generating roughly 0.1 per unit of risk. Columbia Banking System shows prevailing Real Value of $42.55 per share. The current price of the firm is $39.26. At this time the firm appears to be undervalued. This module approximates value of Columbia Banking System from analyzing the firm fundamentals such as Profit Margin of 33.20 , Return On Equity of 9.32  and Shares Outstanding of 72.14 M as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
 Columbia Banking  risk ideas   columbia banking financial services banks - regional banking banks?regional
  over two weeks ago at Macroaxis 
By Ellen Johnson
This article is intended for all current DNA BRANDS investors and for investors considering a position in the company. I will inspect if investors should continue to be optimistic for the company outlook. DNA BRANDS INC chance of financial distress is under   47.00  . Given the investment horizon of 30 days, DNA BRANDS is expected to generate 10.85 times more return on investment than the market. However, the company is 10.85 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The market is currently generating roughly 0.1 per unit of risk. What is DNA BRANDS Target Price Odds to finish over Current Price? Based on normal probability distribution, the odds of DNA BRANDS to move above current price in 30 days from now is about 52.99%. The DNA BRANDS INC probability density function shows the probability of DNA BRANDS OTC Stock to fall within a particular range of prices over 30 days . Given the investment horizon of 30 days, DNA BRANDS INC has beta of -0.2149 suggesting as returns on benchmark increase, returns on holding DNA BRANDS are expected to decrease at a much smaller rate. During bear market, however, DNA BRANDS INC is likely to outperform the market. Additionally, the company has an alpha of 0.1764 implying that it can potentially generate 0.1764% excess return over Russell 2000 after adjusting for the inherited market risk (beta).
 DNA BRANDS  risk ideas   dna brands consumer defensive beverages?non-alcoholic
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
Today post will break down Equinix. I will inspect why investors should continue to be optimistic in the company outlook. This firm Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, Equinix is expected to generate 53.11 times less return on investment than the market. In addition to that, the company is 1.05 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The market is currently generating roughly 0.07 per unit of volatility. Equinix shows prevailing Real Value of $569.31 per share. The current price of the firm is $544.71. At this time the firm appears to be undervalued. This module computes value of Equinix from reviewing the firm fundamentals such as Shares Outstanding of 84.82 M, Profit Margin of (0.06)  and Current Valuation of 58.7 B as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
 Equinix  risk ideas   equinix real estate reit - specialty trading reit?specialty
  over a month ago at Macroaxis 
By Achuva Shats
My story will go over IBERIABANK. I will evaluate if IBERIABANK shares are reasonably priced going into December. IBERIABANK Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, IBERIABANK is expected to generate 1.2 times more return on investment than the market. However, the company is 1.2 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The market is currently generating roughly 0.08 per unit of risk. We found thirty-three available reported financial drivers for IBERIABANK which can be compared to its competitors. To make sure the equity is not overpriced, please check out all IBERIABANK fundamentals including its Shares Owned by Insiders, Revenue, Total Debt, as well as the relationship between Price to Earning and Net Income . Given that IBERIABANK has Price to Earning of 10.03 , we strongly advise you confirm IBERIABANK regular market performance to make sure the company can sustain itself in the future. Use IBERIABANK to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of IBERIABANK to be traded at $86.02 in 30 days.
 IBERIABANK  risk ideas   iberiabank financial services banks - regional banking banks?regional

Share Stories

Syndicate Stories to major social sites

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Search macroaxis.com